The iron(II)-nitroxyl complex [Fe(NO)-( L3)] (1) (with L3 − = a hindered hydrotris(pyrazolyl)borate ligand), a high-spin (hs)-{FeNO} 8 complex in the Enemark−Feltham notation, is surprisingly stable and is the first of its kind that could be structurally characterized. We further studied this compound using a variety of spectroscopic methods. These results indicate a hs iron(II) center with a bound 3 NO − ligand where the spins are antiferromagnetic coupled (S t = 1). Vibrational data show that this complex has a very strong Fe−NO bond. DFT calculations support this result and link it to very strong π-donation from the 3 NO − ligand to the iron(II) center. Furthermore, a very unusual equilibrium between the hs-{FeNO} 8 complex and a dinitrosyl iron complex (DNIC) of {Fe(NO) 2 } 9 type is observed. The O 2 reactivity of the complex is finally reported.
The α-ketocarboxylatocopper(II) complex [{Cu(L1)}{O2CC(O)CH(CH3)2}] can be spontaneously converted into the binuclear oxalatocopper(II) complex [{Cu(L1)}2(μ-C2O4)] upon exposure to O2/CO2 gas. (13)C-labeling experiments revealed that oxalate ions partially incorporated (13)CO2 molecules. Furthermore, the bicarbonatocopper(I) complex (NEt4)[Cu(L1){O2C(OH)}] in an Ar atmosphere and the α-ketocarboxylatocopper(I) complex Na[Cu(L1){O2CC(O)CH(CH3)2}] in an O2 atmosphere were also transformed spontaneously into the oxalato complex [{Cu(L1)}2(μ-C2O4)].
The cobalt-nitrosyl complex [Co(NO)(L3)] is supported by a highly hindered tridentate nitrogen ligand, hydrotris(3-tertiary butyl-5-isopropyl-1-pyrazolyl)borate (denoted as L3), and shows a linear Co-N-O unit. This complex was prepared by the reaction of the potassium salt of L3 with the cobalt-nitrosyl precursor [Co(NO)(tmeda)](BPh) (tmeda = N,N,N,'N'-tetramethylethylenediamine). The obtained cobalt-nitrosyl complex as well as the corresponding products from the reaction with dioxygen, [Co(η-ON)(L3)] and [Co(η-ONO)(L3)], were characterised by X-ray crystallography and a number of spectroscopic methods including IR/far-IR, UV-Vis, and NMR spectroscopy. We also performed MCD measurements and DFT calculations to further elucidate the electronic structure of [Co(NO)(L3)] and the optical properties of the complex. The MCD spectra reveal two NO-to-Co charge-transfer transitions with strong excited state displacements that give rise to vibrational progressions in the MCD spectra, indicative of a very covalent Co-NO bond. These results provide new insight into the properties of the Co-NO bond and the electron distribution in the complex, which is best described as [Co(NO)(L3)].
The linear nickel-nitrosyl complex [Ni(NO)(L3)] supported by a highly hindered tridentate nitrogen-based ligand, hydrotris(3-tertiary butyl-5-isopropyl-1-pyrazolyl)borate (denoted as L3), was prepared by the reaction of the potassium salt of the ligand with the nickel-nitrosyl precursor [Ni(NO)(Br)(PPh 3 ) 2 ]. The obtained nitrosyl complexes as well as the corresponding chlorido complexes [Ni(NO)(Cl)(PPh 3 ) 2 ] and [Ni(Cl)(L3)] were characterized by X-ray crystallography and different spectroscopic methods including IR/far-IR, UV-Vis, NMR, and multi-edge X-ray absorption spectroscopy at the Ni K-, Ni L-, Cl K-, and P K-edges. For comparative electronic structure analysis we also performed DFT calculations to further elucidate the electronic structure of [Ni(NO)(L3)]. These results provide the nickel oxidation state and the character of the Ni-NO bond. The complex [Ni(NO)(L3)] is best described as [Ni (II) (NO (-) )(L3)], and the spectroscopic results indicate that the phosphane complexes have a similar [Ni (II) (NO (-) )(X)(PPh 3 ) 2 ] ground state.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.